Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Labiotech.eu

05:51 EST 18th February 2018 | BioPortfolio

Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.

More Information about Labiotech.eu on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.

Showing News Articles 1–25 of 1,200+ from Labiotech.eu

Friday 16th February 2018

More News! An Avalanche of Partnerships and Fundraisings This Week

Try as we might, we can’t cover all the biotech news out there! This week has been intense for biotech finance with multiple deals and fundraisings announced. Oxford-based Scancell will use ISA Pharmaceuticals’ technology to manufacture its cancer immunotherapy, Modi-1. Preclinical data shows that ... This awesome article More News! An Avalanche of Partnerships and Fundraisings This We...

French Biotech Gets a CRISPR Patent for CAR-T Research

Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to use CRISPR technology to make CAR-T cells. Cellectis has said it will offer licenses to companies that want to use CRISPR ... This awesome article French Biotech Gets a CRISPR Patent for CAR-T Research appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

This Bavarian Biotech Offers Better Drug Delivery to Boost Efficacy and Tolerability

This week, we’re in the Bavarian region of Germany to check out XL-Protein, a biotech that improves drug delivery by modifying the drugs we use to help them stay in the body for longer. Mission: XL-Protein has found a way to slow ... This awesome article This Bavarian Biotech Offers Better Drug Delivery to Boost Efficacy and Tolerability appeared first on Labiotech.eu. Be kind and don't co...

Thursday 15th February 2018

This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39%

The wireless system for diabetes management developed by Cellnovo can significantly reduce life-threatening events of hypoglycemia in patients with type 1 diabetes.  A clinical study that followed type 1 diabetes patients for a year has concluded that a new mobile ... This awesome article This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39% appeared first on Labiotech.eu. Be kind...

Startup Studio Raises €90M to Create and Develop Exciting Young Biotechs

iBionext has closed its Growth Fund, which has raised money from investors like Bpifrance to help young biotechs to reach their potential. iBionext is a French ‘startup studio’ that specializes in the creation and development of startups in the healthcare industry. ... This awesome article Startup Studio Raises €90M to Create and Develop Exciting Young Biotechs appeared first on Lab...

Здравствуйте – Russian Talent For Labiotech.eu

You may have noticed last year that we started improving our graphic identity. With the help of the wonderful Alfredo, we gave ourselves a sparkly new makeover to help show our brilliant personality and wicked flair. Sadly we had to ... This awesome article Здравствуйте – Russian Talent For Labiotech.eu appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Wednesday 14th February 2018

This Biotech Veteran Is Using These Tips for Successful Drug Development, Here Is Why

Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate Partners and Apeiron’s CFO and CBO. He told us how he found himself at the biotech and shared the lessons he learned on his way ... This awesome article This Biotech Veteran Is Using These Tips for Successful Drug Development, Here Is Why appeared first on Labiotech.eu. Be kind and don't cop...

Peter Llewellyn-Davies Gives Us His Tips for Successful Drug Development and Partnerships 

Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate Partners and Apeiron’s CFO and CBO. He told us how he found himself at the biotech and shared the lessons he learned on his way ... This awesome article Peter Llewellyn-Davies Gives Us His Tips for Successful Drug Development and Partnerships  appeared first on Labiotech.eu. Be kind and don...

Anti-Antibiotic Resistance Technology Gets Fast-Tracked to Phase III

Allecra Therapeutics’ candidate that blocks the development of antibiotic resistance has been awarded the FDA’s Fast Track Designation and will enter Phase III this summer. Allecra Therapeutics, our biotech of the week a few weeks ago, develops new treatments for multidrug-resistant Gram-negative ... This awesome article Anti-Antibiotic Resistance Technology Gets Fast-Tracked to Phas...

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

A collaboration between Bicycle Therapeutics and Cancer Research UK has yielded its first peptide to enter clinical trials for solid tumors. Bicycle Therapeutics, the pioneer of the bicyclic peptide platform, has dosed the first patient in a Phase I/IIa trial ... This awesome article Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors appeared first on Labiotech.eu. Be...

Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food

Nuritas and Nestlé will use artificial intelligence to find bioactive peptides in the food we eat for applications including diabetes, anti-aging, and animal and plant health. Nuritas wants to revolutionize the discovery of natural active ingredients that can support and improve ... This awesome article Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food appeared first on Labiotech.e...

Step Up To The Challenge of a New Biotech Job!

Hello biotechnologists, Rise to the challenge and take the stairway to biotech employment. We’re here to help with this list of jobs and internships! Interested in prophylactic vaccines? Check out the position at CureVac! Just starting out? Take a look at the ... This awesome article Step Up To The Challenge of a New Biotech Job! appeared first on Labiotech.eu. Be kind and don't copy it wi...

Tuesday 13th February 2018

ProQR Tackles Blindness Caused by a Rare Genetic Disease

ProQR has received €6M from the American charity, Foundation Fighting Blindness, for the development of its treatment for Usher Syndrome – the leading cause of combined blindness and deafness. ProQR focuses on the development of RNA-based medicines for genetic diseases like cystic ... This awesome article ProQR Tackles Blindness Caused by a Rare Genetic Disease appeared first on Labiotec...

ProQR Tackles Blindness and Deafness Caused by a Rare Genetic Disease

ProQR has received €6M from the American charity, Foundation Fighting Blindness, for the development of its treatment for Usher Syndrome – the leading cause of combined blindness and deafness. ProQR focuses on the development of RNA-based medicines for genetic diseases like cystic ... This awesome article ProQR Tackles Blindness and Deafness Caused by a Rare Genetic Disease appeared firs...

Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval

Update (13/02/2018): The European Commission has given Novo Nordisk a market authorization for Ozempic (semaglutide), bringing the competition for Eli Lilly’s Trulicity over to Europe. Eli Lilly executives have said that they are not worried by Novo’s competition, and keep confident ... This awesome article Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval...

British Cancer Vaccine Boosts 5-Year Survival in Late Stage Melanoma

Scancell has reported promising 5-year survival data for its cancer vaccine SCIB1, with a second trial expected to start later this year. Scancell has published data from its ongoing Phase I/II trial in patients with stage III and IV melanoma in the journal OncoImmunology. ... This awesome article British Cancer Vaccine Boosts 5-Year Survival in Late Stage Melanoma appeared first on Labiotech....

Erytech’s ‘Armed’ Red Blood Cells Will be Tested Against Triple Negative Breast Cancer

Erytech will test its Graspa technology for the treatment of a second solid tumor indication, breast cancer, following its success in pancreatic cancer. French biotech Erytech has developed an exciting platform for the treatment of cancer called Graspa, which encapsulates L-asparaginase in red ... This awesome article Erytech’s ‘Armed’ Red Blood Cells Will be Tested Against Tr...

High-Speed Healing Could Prevent the Infection of Chronic Wounds

Swedish scientists have used bacteria to deliver a chemical into wounds that speeds up the healing process. This could help to prevent their infection with dangerous strains of resistant bacteria. Researchers at Uppsala University have identified a technique to accelerate ... This awesome article High-Speed Healing Could Prevent the Infection of Chronic Wounds appeared first on Labiotech.eu. Be ki...

How is Biotech Innovating to Treat Hemophilia? Let’s Review

Experts say hemophilia treatment is at a ‘precipice of a therapeutic revolution.’ From antibodies to gene therapy, here are some of the most innovative technologies in the field that might significantly improve the lives of patients suffering from this bleeding ... This awesome article How is Biotech Innovating to Treat Hemophilia? Let’s Review appeared first on Labiotech.eu. Be ...

Monday 12th February 2018

No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug

Boehringer Ingelheim has ditched its Alzheimer’s drug after it failed to meet the endpoints of a Phase II trial but will continue to look at it for the treatment of schizophrenia. One of Germany’s biggest pharma companies, Boehringer Ingelheim, has given up ... This awesome article No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug appeared first on Lab...

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development and commercialization of imeglimin, a new treatment for metabolic disorders like type 2 diabetes. Poxel uses its expertise in metabolism to develop drugs for the ... This awesome article Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide appeared first on Lab...

First Functioning Kidney Tissue Generated from Embryonic Stem Cells

Researchers at the University of Manchester have used embryonic stem cells to produce kidney tissue that can filter the blood to produce urine, which opens the door to personalized kidney transplants. Scientists at the University of Manchester have generated human kidney ... This awesome article First Functioning Kidney Tissue Generated from Embryonic Stem Cells appeared first on Labiotech.eu. Be...

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

After 25 years, MorphoSys finally got over the line in 2017 with the FDA approval of its first antibody. CEO Simon Moroney tells us how the company hopes to build on its recent success. It may have started out as ... This awesome article MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Saturday 10th February 2018

Superbugs: Fighting Antibiotic Resistance at the Science Museum

An exhibition at the Science Museum London features some of the deadliest superbugs on Earth and the stories of the people fighting against the threat of antibiotic resistance.  It is estimated that, by 2050, 10 million people will die every ... This awesome article Superbugs: Fighting Antibiotic Resistance at the Science Museum appeared first on Labiotech.eu. Be kind and don't copy it without as...

Friday 9th February 2018

This Polish Biotech Uses AI to Help Others Speed Up Precision Medicine Development

Following on from BioNext’s software last week, we’re in Kraków to visit Ardigen. This biotech develops technology to help us decipher the huge amount of data generated by research. Mission: Ardigen came to our attention when it finished 2nd place in the prestigious ... This awesome article This Polish Biotech Uses AI to Help Others Speed Up Precision Medicine Development appeared ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks